Widespread occurrence of an infectious disease is most common in the less hygienic areas, and where hospitals and long-term care centers are struggling to maintain hygienic condition, especially in surgical and orthopedic wards. Hospitals, and other healthcare centers are turning to software analytical tools for solutions. Infection surveillance analytics help organize and interpret health data by investigating the various parameters, and incorporation those for the implementation and estimation of public health practice; to control the frequency of healthcare associated infections. These nosocomial infections mostly occur in patients after admission to hospitals and these kind of infections decrease the immunity in patients, as there is already a prevailing infection of a different disease; the chances of epidemic are more due to weak infection control practices.
Increasing Investment in Healthcare Spending and Changing Healthcare Scenario Fuel the Growth for Infection Surveillance Solutions
Proactive government measures, like the Affordable Care Act and the other policies continued to have an impact on the growth of healthcare spending in 2015. Additionally, faster growth took place because of improved hospital care, private health insurance, and technology implementation in dealing with the patients’ health problems. This trend has triggered the usage of advanced technological tools, like infection surveillance solutions, to maintain the hygienic conditions in hospitals. About 45% of US hospitals now use electronic surveillance systems (ESS), and it is expected to increase further in the near future where these systems are integrated with the infection surveillance solution software services.
The healthcare sector is moving from its traditional, fragmented approach to financial and better clinical operations focused on connectivity and convergence. For instance, in the US, increasing healthcare costs are making individual hospitals move, or merge with independent healthcare groups to form larger health systems that can broaden their service reach, leverage economies of scale and also can withstand rising regulatory pressures from the recent government. These dynamics are influencing the growth of the technological advances in the hospital, which in turn, boost the infection surveillance solutions market.
The Widespread Growth of Infections in Long-term Care Facilities is expected to Increase their Adoption in the Domain
Long-term care facilities or LTCFs are a collective of skilled nursing facilities, nursing homes and assisted living facilities. They usually provide a variety of services, both personal and medical care, to the people who are unable to manage independently in the community. Whereas, in the US alone, over 4 million people are admitted in these LTCFs each year and around one million persons reside in assisted living facilities. These facilities are effected by a serious infection, where 1 to 3 million people affected by these infections each year in these facilities. Infections include diarrheal diseases, urinary tract infection, and other infections.
In 2015, a reported 1.6 billion people required mass or individual treatment and care for neglected tropical diseases (NTDs). Due to these factors LTCFs are trying to adopt advanced technological tools to reduce infection rates. Infection surveillance solution tools can program and design the prevention of the spread of infection in healthcare environments. When these elements are practiced consistently, the risk of infection among patients can be reduced over a period. Most of the patients are institutionalized in these facilities, because they have significant impaired functional and chronic illnesses. These, to certain degree, are also associated with the risk of infection with resistant organisms.
United States is one of the Prime Markets for the Adoption of Infection Surveillance Solutions Technology
North America is one of the largest markets for medical technology research industries, globally. The huge market in the region is mainly due to growing R&D activities in medical sciences. Particularly in the United States of America Health and Human Services (HHS), which is governed by the cabinet-level department of the US federal government is very liberal in funding and maintaining the technological research in medical sciences.
As new technological developments are growing rapidly in medical field, now in mergence with analytical technology, there is a strong focus on improving the health conditions of people, as well as tackling the adverse effects from the increasing health diseases and infections. For example, surgical wound infections are a common cause of nosocomial infections, and nearly 30 million patients suffer from the surgical site infections (SSI) each year. Each year, this number grows and it is proportional to rise in number of surgeries in the United States.
Moreover, healthcare associated infections (HAIs) are even increasing at faster rate, which is creating major concern regarding patient safety. As many of these infections occur in the intensive care unit (ICU), hospitals are facing struggles in reducing the infection rate. The annual hospital cost of HAIs is around USD 33 billion per year, in the United States. Due to these issues, the US Department of Health and Human Services made it a priority and made it as a national reduction of HAIs with the objective of building a safer, more inexpensive healthcare system, for all Americans.
Key Developments in the Market
- March 2018 - Owing to the recent molecular surveillance conducted in US, about 60 clusters of HIV are detected which have been rapidly growing in the country. The median rate of transmission for the disease for the clusters has been 44 infections per 100 persons, while the national average is at 4 persons per 100
- March 2018 - Excellus BlueCross BlueShield has relied on financial incentives to improve healthcare facilities. Last year the non-profit organization had paid 10 area hospitals a total amount of $948,447 in quality improvement payments, which is expected to increase the need for infection surveillance equipment
Reasons to Purchase this Report
- Growing healthcare expenditure acts as a driver to the infection surveillance solutions market scenario
- Analyzing various perspectives of the market with the help of Porter’s five forces analysis
- The end-user that is expected to dominate the market is analyzed in detail
- The regions that are expected to witness fastest growth during the forecast period are analyzed and estimated for growth
- Identifying the latest developments, market shares and strategies employed by the major market players
- 3-month analyst support, along with the Market Estimate sheet (in Excel)
This report can be customized to meet your requirements. Please contact us for more information.
1.1 Key Study Deliverables
1.2 Market Definition
1.3 Study Assumptions
2. Research Methodology
3. Executive Summary
4. Market Insights
4.1 Market Overview
4.2 Indusrty Attractiveness- Porter'S Five Forces Analysis
4.2.1 Threat of New Entrants
4.2.2 Bargaining Power of Suppliers
4.2.3 Bargaining Power of Consumers
4.2.4 Threat of Substitute Products
4.2.5 Intensity of Competitive Rivalry
4.3 Industry Value Chain Analysis
4.4 Industry Policies
5. Market Dynamics
5.1 Market Drivers
5.1.1 Pro-active Government Policies for Preventing Hospital Associated Infections
5.1.2 Increasing Healthcare Expenditure
5.1.3 Rise in the Number of Surgeries
5.2 Market Restraints
5.2.1 Reluctance among Medical Professionals to Adopt Advanced Healthcare Tools
5.2.2 Dearth of Skilled It Professionals in the Healthcare Industry
6. Technology Snapshot
7. Global Infection Surveillance Solutions Market Segmentation
7.1 By Product
18.104.22.168 Maintenance and Support
22.214.171.124 Consultation and Training
126.96.36.199 Implementation Services
7.2 By End-user
7.2.2 Long-term Care Facilities
7.3 By Geography
7.3.1 North America
188.8.131.52 Rest of Europe
184.108.40.206 Rest of Asia-Pacific
7.3.4 Latin America
220.127.116.11 Rest of Latin America
7.3.5 Middle East & Africa
18.104.22.168 Saudi Arabia
22.214.171.124 Rest of Middle East & Africa
8. Vendor Market Share
9. Key Vendor Profiles
9.1 Becton, Dickinson and Company
9.2 Premier Inc.
9.3 DEB Group Ltd.
9.4 RL Solutions
9.5 Hygreen Inc.
9.6 Baxter International Inc.
9.7 Atlas Medical Software
9.8 Gojo Industries Inc.
9.9 ICNet International Limited
9.10 Wolters Kluwer N.V.
9.11 Truven Health Analytics
*List not Exhaustive
10. Investment Analysis
10.1 Recent Mergers And Acquisitions
10.2 Investment Scenario And Opportunities
11. Future of Infection Surveillence Solutions Market
- Dickinson and Company
- Premier Inc.
- DEB Group Ltd.
- RL Solutions
- Hygreen Inc.
- Baxter International Inc.
- Atlas Medical Software
- Gojo Industries Inc.
- ICNet International Limited
- Wolters Kluwer N.V.
- Truven Health Analytics.